Literature DB >> 6272972

Fatal Epstein-Barr virus infection in a child with acute lymphoblastic leukemia in remission.

A T Look, R F Naegele, T Callihan, H G Herrod, W Henle.   

Abstract

A 9-year-old white boy developed a fatal primary Epstein-Barr virus (EBV) infection while receiving chemotherapy for acute lymphoblastic leukemia in remission. Histopathological findings at the height of the proliferative phase of the illness were compatible with a virally induced hemophagocytic syndrome. The infection spontaneously converted to complete aplasia of the bone marrow and lymph nodes. Serological studies disclosed that the patient had no antibodies to EBV prior to the infection, but during the acute phase he showed a spectrum and titers of antibodies to EBV-specific antigens characteristic of a current primary EBV infection. A lymph node biopsy obtained 5 weeks after onset revealed Epstein-Barr nuclear antigen in approximately 50% of the cells. The boy's condition deteriorated rapidly, with disseminated candidiasis resulting in cardiorespiratory failure and death. Lymph nodes obtained at autopsy no longer contained Epstein-Barr nuclear antigen-positive cells.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6272972

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  4 in total

1.  Angiocentric immunoproliferative lesion and angiocentric lymphoma of lymph node in children. A report of two cases.

Authors:  R Drut; R M Drut
Journal:  J Clin Pathol       Date:  2005-05       Impact factor: 3.411

2.  Monoclonal proliferation of Epstein-Barr virus-infected T-cells in a patient with virus-associated haemophagocytic syndrome.

Authors:  T Noma; K Kou; I Yoshizawa; Y Kawano; T Miyashita; S Mizutani; J Yata
Journal:  Eur J Pediatr       Date:  1994-10       Impact factor: 3.183

3.  Central nervous system involvement of epstein barr virus associated lymphoproliferative disorder in a child with acute lymphoblastic leukemia: successful treatment with rituximab and interferon-alpha.

Authors:  Berna Atabay; Meral Türker; Can Oztürk; Sümer Sütçüoğlu; Haldun Oniz; Esra Arun Ozer
Journal:  Turk J Haematol       Date:  2013-03-05       Impact factor: 1.831

Review 4.  Progress in Treatment of Viral Infections in Children with Acute Lymphoblastic Leukemia.

Authors:  Maria Moschovi; Maria Adamaki; Spiros A Vlahopoulos
Journal:  Oncol Rev       Date:  2016-06-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.